# ZNRD2

## Overview
ZNRD2, or zinc ribbon domain containing 2, is a gene that encodes a protein involved in various cellular processes, particularly in protein quality control and regulatory mechanisms. The protein encoded by ZNRD2 is characterized by its zinc ribbon domain, which is a structural motif often associated with nucleic acid binding and protein-protein interactions. ZNRD2 plays a significant role in the ubiquitination pathway, specifically through its interaction with the HERC2-ZNRD2 complex, which is crucial for the initial recognition and mono-ubiquitination of orphaned proteins, setting the stage for their subsequent degradation by the proteasome (Roas2024Convergence). Additionally, ZNRD2 has been implicated in various diseases, including otosclerosis and major depression, through its genetic variants and interactions with transcription factors (PérezGranado2022Functional; Rämö2023Genomewide). The gene is also associated with cancer, particularly through its link to the Sjögren syndrome/scleroderma autoantigen 1 (SSSCA1), which is involved in the Wnt signaling pathway (PerdreauDahl2020Sjögren).

## Clinical Significance
ZNRD2 (zinc ribbon domain containing 2) has been implicated in various diseases through alterations in its expression or interactions. In the context of otosclerosis, a genome-wide study identified ZNRD2 as having a causal posterior probability of 6.3% in relation to the condition, suggesting its potential role in genetic susceptibility to otosclerosis (Rämö2023Genomewide). This study highlights the polygenic nature of otosclerosis, with ZNRD2 being one of the genes potentially influencing susceptibility.

In the realm of mental health, ZNRD2 is involved in genetic variants associated with major depression. A study identified a genetic variant, rs11227217, which affects the transcription factor RAD21 and its interaction with ZNRD2-DT, a related transcript, indicating a potential role in the regulation of gene expression linked to major depression (PérezGranado2022Functional).

ZNRD2 is also associated with cancer, as it is linked to the Sjögren syndrome/scleroderma autoantigen 1 (SSSCA1), which is overexpressed in several cancers, including colorectal cancer. SSSCA1, part of the ZNRD2 family, is involved in the Wnt signaling pathway, a critical pathway in cancer progression (PerdreauDahl2020Sjögren).

## Interactions
ZNRD2 is involved in the degradation of orphaned proteins through its interaction with the HERC2-ZNRD2 complex. This complex plays a crucial role in the initial recognition and mono-ubiquitination of orphaned proteins, such as CCT4, which is a necessary step before further poly-ubiquitination by the UBR4-KCMF1 complex. The interaction between ZNRD2 and HERC2 is essential for this initial ubiquitination process, which sets the stage for subsequent degradation by the proteasome (Roas2024Convergence).

In the context of genetic variants associated with major depression, ZNRD2 is implicated in a mechanistic association involving transcription factors. Specifically, the genetic variant rs11227217 is associated with the transcription factor RAD21, which in turn is linked to ZNRD2-DT, suggesting a regulatory interaction that may influence gene expression (PérezGranado2022Functional).

While ZNRD2 is mentioned in various studies, specific details about its interactions with other proteins or nucleic acids beyond the ubiquitination pathway are not extensively detailed in the available context. The role of ZNRD2 in these interactions highlights its potential involvement in cellular regulatory mechanisms and protein quality control pathways.


## References


[1. (PérezGranado2022Functional) Judith Pérez-Granado, Janet Piñero, Alejandra Medina-Rivera, and Laura I. Furlong. Functional genomics analysis to disentangle the role of genetic variants in major depression. Genes, 13(7):1259, July 2022. URL: http://dx.doi.org/10.3390/genes13071259, doi:10.3390/genes13071259. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes13071259)

[2. (Rämö2023Genomewide) Joel T. Rämö, Tuomo Kiiskinen, Richard Seist, Kristi Krebs, Masahiro Kanai, Juha Karjalainen, Mitja Kurki, Eija Hämäläinen, Paavo Häppölä, Aki S. Havulinna, Heidi Hautakangas, Reedik Mägi, Priit Palta, Tõnu Esko, Andres Metspalu, Matti Pirinen, Konrad J. Karczewski, Samuli Ripatti, Lili Milani, Konstantina M. Stankovic, Antti Mäkitie, Mark J. Daly, and Aarno Palotie. Genome-wide screen of otosclerosis in population biobanks: 27 loci and shared associations with skeletal structure. Nature Communications, January 2023. URL: http://dx.doi.org/10.1038/s41467-022-32936-3, doi:10.1038/s41467-022-32936-3. This article has 2 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-022-32936-3)

[3. (PerdreauDahl2020Sjögren) Harmonie Perdreau-Dahl, Cinzia Progida, Stefan J. Barfeld, Hanne Guldsten, Bernd Thiede, Magnus Arntzen, Oddmund Bakke, Ian G. Mills, Stefan Krauss, and J. Preben Morth. Sjögren syndrome/scleroderma autoantigen 1 is a direct tankyrase binding partner in cancer cells. Communications Biology, March 2020. URL: http://dx.doi.org/10.1038/s42003-020-0851-2, doi:10.1038/s42003-020-0851-2. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s42003-020-0851-2)

4. (Roas2024Convergence) Convergence of orphan quality control pathways at a ubiquitin chain-elongating ligase. This article has 0 citations.